130 related articles for article (PubMed ID: 16000412)
1. Evaluation of PCR for diagnosis of Indian kala-azar and assessment of cure.
Maurya R; Singh RK; Kumar B; Salotra P; Rai M; Sundar S
J Clin Microbiol; 2005 Jul; 43(7):3038-41. PubMed ID: 16000412
[TBL] [Abstract][Full Text] [Related]
2. PCR for diagnosis and assessment of cure in kala-azar patients in Bangladesh.
Salam MA; Mondal D; Kabir M; Ekram AR; Haque R
Acta Trop; 2010 Jan; 113(1):52-5. PubMed ID: 19769932
[TBL] [Abstract][Full Text] [Related]
3. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis.
Salotra P; Sreenivas G; Pogue GP; Lee N; Nakhasi HL; Ramesh V; Negi NS
J Clin Microbiol; 2001 Mar; 39(3):849-54. PubMed ID: 11230394
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of symptomatic kala-azar by polymerase chain reaction using patient's blood.
Pal S; Aggarwal G; Haldar A; Majumdar A; Majumdar HK; Duttagupta S
Med Sci Monit; 2004 Jan; 10(1):MT1-5. PubMed ID: 14704640
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of a new Leishmania PCR for clinical visceral leishmaniasis in Nepal and its role in diagnosis of disease.
Deborggraeve S; Boelaert M; Rijal S; De Doncker S; Dujardin JC; Herdewijn P; Büscher P
Trop Med Int Health; 2008 Nov; 13(11):1378-83. PubMed ID: 18803611
[TBL] [Abstract][Full Text] [Related]
6. A new PCR-ELISA for diagnosis of visceral leishmaniasis in blood of HIV-negative subjects.
De Doncker S; Hutse V; Abdellati S; Rijal S; Singh Karki BM; Decuypere S; Jacquet D; Le Ray D; Boelaert M; Koirala S; Dujardin JC
Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):25-31. PubMed ID: 15550258
[TBL] [Abstract][Full Text] [Related]
7. An experimental study on application of PCR in detection of kala-azar.
Wu Z; Bao Y; Ding Y; Yu M; Lu L; Zhang Y
Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):169-72. PubMed ID: 9322302
[TBL] [Abstract][Full Text] [Related]
8. Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1.
Pizzuto M; Piazza M; Senese D; Scalamogna C; Calattini S; Corsico L; Persico T; Adriani B; Magni C; Guaraldi G; Gaiera G; Ludovisi A; Gramiccia M; Galli M; Moroni M; Corbellino M; Antinori S
J Clin Microbiol; 2001 Jan; 39(1):357-61. PubMed ID: 11136800
[TBL] [Abstract][Full Text] [Related]
9. Urine antigen detection by latex agglutination test for diagnosis and assessment of initial cure of visceral leishmaniasis.
Salam MA; Khan MG; Mondal D
Trans R Soc Trop Med Hyg; 2011 May; 105(5):269-72. PubMed ID: 21353275
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity and specificity of the Leishmania OligoC-TesT and NASBA-oligochromatography for diagnosis of visceral leishmaniasis in Kenya.
Basiye FL; Mbuchi M; Magiri C; Kirigi G; Deborggraeve S; Schoone GJ; Saad AA; El-Safi S; Matovu E; Wasunna MK
Trop Med Int Health; 2010 Jul; 15(7):806-10. PubMed ID: 20487428
[TBL] [Abstract][Full Text] [Related]
11. Leishmania infantum DNA detection in urine from patients with visceral leishmaniasis and after treatment control.
Fisa R; Riera C; López-Chejade P; Molina I; Gállego M; Falcó V; Ribera E; Portús M
Am J Trop Med Hyg; 2008 May; 78(5):741-4. PubMed ID: 18458307
[TBL] [Abstract][Full Text] [Related]
12. Application of loop-mediated isothermal amplification assay for the sensitive and rapid diagnosis of visceral leishmaniasis and post-kala-azar dermal leishmaniasis.
Verma S; Avishek K; Sharma V; Negi NS; Ramesh V; Salotra P
Diagn Microbiol Infect Dis; 2013 Apr; 75(4):390-5. PubMed ID: 23433714
[TBL] [Abstract][Full Text] [Related]
13. Comparison of treatment regimens of kala-azar based on culture & sensitivity of amastigotes to sodium antimony gluconate.
Thakur CP; Thakur S; Narayan S; Sinha A
Indian J Med Res; 2008 Jun; 127(6):582-8. PubMed ID: 18765878
[TBL] [Abstract][Full Text] [Related]
14. A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy.
Gelanew T; Amogne W; Abebe T; Kuhls K; Hailu A; Schönian G
Br J Dermatol; 2010 Oct; 163(4):870-4. PubMed ID: 20331449
[TBL] [Abstract][Full Text] [Related]
15. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
Mandal S; Maharjan M; Singh S; Chatterjee M; Madhubala R
J Antimicrob Chemother; 2010 Mar; 65(3):496-507. PubMed ID: 20067981
[TBL] [Abstract][Full Text] [Related]
16. Use of the polymerase chain reaction to assess the success of visceral leishmaniasis treatment.
Osman OF; Oskam L; Zijlstra EE; el-Hassan AM; el-Naeim DA; Kager PA
Trans R Soc Trop Med Hyg; 1998; 92(4):397-400. PubMed ID: 9850390
[TBL] [Abstract][Full Text] [Related]
17. The molecular characterization of clinical isolates from Indian Kala-azar patients by MLEE and RAPD-PCR.
Manna M; Majumder HK; Sundar S; Bhaduri AN
Med Sci Monit; 2005 Jul; 11(7):BR220-7. PubMed ID: 15990683
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of kala-azar by nested PCR based on amplification of the Leishmania mini-exon gene.
Katakura K; Kawazu S; Naya T; Nagakura K; Ito M; Aikawa M; Qu JQ; Guan LR; Zuo XP; Chai JJ; Chang KP; Matsumoto Y
J Clin Microbiol; 1998 Aug; 36(8):2173-7. PubMed ID: 9665985
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic PCR with Leishmania donovani specificity using sequences from the variable region of kinetoplast minicircle DNA.
Singh N; Curran MD; Rastogil AK; Middleton D; Sundar S
Trop Med Int Health; 1999 Jun; 4(6):448-53. PubMed ID: 10444321
[TBL] [Abstract][Full Text] [Related]
20. Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India.
Dey A; Singh S
Infect Genet Evol; 2007 Mar; 7(2):219-22. PubMed ID: 17027344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
